Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > BUSINESS
BUSINESS
- Astellas’ FY2013 Funding to Medical Institutions Totals 18.7 Billion Yen
September 2, 2014
- 33.2 Billion Yen Paid to Medical Institutions in FY2013: Daiichi Sankyo
September 2, 2014
- Takeda’s Payments to Health Professionals Down 30% in FY2013
September 2, 2014
- Kyowa Kirin Initiates PIIb Study of Regpara Successor in Japan
September 2, 2014
- Kyowa Kirin Merges Ethics Office into CSR Promotion Dept., Following Improper Involvement of Its Employees in Clinical Study
September 2, 2014
- 10-Year Epidemiology Study Finds No Significant Increase in Bladder Cancer Risk from Actos: Takeda
September 1, 2014
- Novartis Pharma Submits Improvement Plan, Notifies of Over 2,500 Unreported Serious ADRs
September 1, 2014
- Mundipharma Begins PII Trial on Antifolate Pralatrexate in Japan
September 1, 2014
- Daiichi Sankyo Forms Sales Agreement with Kaketsuken for Hepatitis B Vaccine
September 1, 2014
- Fujifilm Starts PI Study of Its Anticancer Agent FF-10501 for Hematological Malignancy in US
September 1, 2014
- Kracie Poised to Re-Enter New Drug Biz with Scabies Treatment
August 29, 2014
- Chugai Provided 17.3 Billion Yen to Healthcare Professionals in 2013, Down 4% from 2012
August 29, 2014
- Sanofi Greater China Head Baschiera to Shepherd Japan Unit
August 29, 2014
- Roche Obtains First Refusal Right for All Chugai’s Products with Partial Amendment to Strategic Alliance Deal
August 29, 2014
- Canaglu to Hit Japan Market on Sept. 3: MTPC, Daiichi Sankyo
August 29, 2014
- Nippon Shinyaku Sets FY2018 Sales Target of 110 Billion Yen, Plans to Focus on Specialty Fields
August 28, 2014
- Novartis Japan Slapped with Warning over Travel Cost Payments for Doctors
August 28, 2014
- MTPC Aims at Over 17% Share for SGLT-2 Inhibitor Canaglu in Japan: Sales Division Head
August 28, 2014
- Otsuka Holdings Takes Aim at 915 Billion Yen Pharma Sales in FY2018 after Abilify Patent Loss
August 27, 2014
- Fixed-Dose Combination HIV Treatment Triumeq Approved in US: ViiV Healthcare
August 27, 2014
ページ
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s leading pharmaceutical wholesalers are bracing for a second consecutive year of profit declines, underscoring the growing challenge of generating…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…